Comparison of three kinds of drugs therapy in ameliorating knee osteoarthritis
Hong-sheng Lin,Zhen-gang Zha,Guo-pu Wang,Zhi-zhong Li,Hao Wu,Ning Liu
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.12.013
2006-01-01
Abstract:AIM: To explore an effective method to treat knee osteoarthritis using drugs. METHODS: Totally 127 patients with knee osteoarthritis, who were diagnosed at the Department of Orthopaedics, First Affiliated Hospital of Jinan University from May 2002 to March 2005, were enrolled and they agreed to accept grouping therapy. They were divided into 3 groups according to the different drugs: 43 cases in diclofenac sodium group, 45 cases in the sodium hyalurate group and 39 cases in the mixed drug group. ①The patients in the diclofenac sodium group were given 75 mg diclofenac sodium, non-steroidalanti-inflammatory antalgica drugs, once a day for 4 weeks. ②Sodium hyalurate 2 mL was injected into articular cavity in the patients of the sodium hyalurate group weekly for 4 weeks. In the first 3 days 75 mg diclofenac sodium was taken daily for 4 weeks. ③2 mL sodium hyalurate was injected into articular space of patients of the mixed drug group weekly for 4 weeks, and in the first 3 days 75 mg diclofenac sodium was given daily, in the same time 2 tablets of glucosamine sulfate capsules was added, 3 times a day for 4 weeks. Knee joint synthetical score (36-0) was performed before treatment and the 2nd, 4th, 8th and 12th weeks after treatment, respectively in patients of every group, including rest pain, exercise pain, joint tenderness, swelling, activity and walking ability, the higher the score, the lighter the synthesis was. RESULTS: A total of 127 patients from 3 groups were involved in the result analysis, without drop out. ①Comparison of knee joint synthetical score before treatment and the 2nd, 4th, 8th and 12th weeks after treatment in patients of every group: Two weeks after taking medicine the highest score in the patients of the diclofenac sodium group was (23.14±2.33), and score decreased at the 4th, 8th and 12th weeks, it was (9.90±2.62) at the 12th week. Two weeks after taking drug in the sodium hyalurate group the score was (24.16±2.76), and at the 4th week it was the highest (30.10±2.49), and (22.90±3.10) at the 12th week. In the mixed drug group the score was (25.13±3.47) at the 2nd week, and reached (31.03±2.25) at the 4th week, it peaked at the 8th and 12th weeks (30.84±2.33) and (30.04±2.18) all the time, respectively. The scores in the patients of the mixed drug group was higher significantly than those in the diclofenac sodium group and the sodium hyalurate group at the 4th, 8th and 12th weeks after taking medicine (P < 0.05-0.01). ②Side effect in patients of each group: In the treatment there was obvious stomach-bowel reaction in the 8 patients of the diclofenac sodium group, and there was no this reaction in the sodium hyalurate group and the mixed drug group. CONCLUSION: Combining diclofenac sodium, sodium hyalurate and glucosamine sulfate can decrease the side effect induced by the non-steroidalanti-inflammatory antalgica drugs for a long time, obtain satisfactory effect in the near future and for a long term, which is an ideal pharmacotherapy.